SEARCH HEALTH CONDITIONS BY ALPHABETS
Hyperlipoproteinemia Type IV, Elevated VLDL
Medications for Hyperlipoproteinemia Type IV, Elevated VLDL
Other titles: Fredrickson Type IV Hyperlipoproteinemia; Hyperlipoproteinemia, Fredrickson Type IV
About Hyperlipoproteinemia Type IV, Elevated VLDL: Hyperlipoproteinemia Type IV has plasma levels of VLDL, pre-β-lipoproteins and triglycerides that are increased to a regular diet, nevertheless β-lipoproteins, cholesterol, and phospholipids are ordinary.
Drugs Used to Heal Hyperlipoproteinemia Type IV, Elevated VLDL
The following list of medications come found in the treating this illness, or somehow associated with.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Niaspan | Rx/OTC | C | N | X | Inch review | 8.0 | |
Generic title: niacin systemic Drug class: nutritional supplements, mixed antihyperlipidemic brokers For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| Lipitor | Rx | X | N | Add review | 0.0 | ||
Generic title: atorvastatin systemic Medication course: statins For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| fenofibrate | Rx | C | N | Add review | 8.0 | ||
Generic title: fenofibrate systemic Brand titles: TriCor, Lipofen, Lofibra, Triglide, Antara, Fenoglide...show all Drug class: fibric acid derivatives For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| atorvastatin | Rx | X | N | Add review | 0.0 | ||
Generic title: atorvastatin systemic Brand title: Lipitor Medication course: statins For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| niacin | Rx/OTC | C | N | X | Inch review | 8.0 | |
Generic title: niacin systemic Brand titles: Niaspan, Niacor, Slo-Niacin, Niacin SR, B-3-50, Nicotinex, B3-500-Gr...reveal all Drug class: nutritional supplements, mixed antihyperlipidemic brokers For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| TriCor | Rx | C | N | Add review | 0.0 | ||
Generic title: fenofibrate systemic Drug class: fibric acid derivatives For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| Crestor | Rx | X | N | Add review | 0.0 | ||
Generic title: rosuvastatin systemic Medication course: statins For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| gemfibrozil | Rx | C | N | Add review | 0.0 | ||
Generic title: gemfibrozil systemic Brand title: Lopid Drug class: fibric acid derivatives For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Zocor | Rx | X | N | Add review | 0.0 | ||
Generic title: simvastatin systemic Medication course: statins For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| Lopid | Rx | C | N | Add review | 0.0 | ||
Generic title: gemfibrozil systemic Drug class: fibric acid derivatives For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| rosuvastatin | Rx | X | N | Add review | 0.0 | ||
Generic title: rosuvastatin systemic Brand title: Crestor Medication course: statins For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| simvastatin | Rx | X | N | Add review | 0.0 | ||
Generic title: simvastatin systemic Brand titles: Zocor, FloLipid Medication course: statins For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Niacor | Rx/OTC | C | N | X | Add review | 0.0 | |
Generic title: niacin systemic Drug class: nutritional supplements, mixed antihyperlipidemic brokers For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| Slo-Niacin | Rx/OTC | C | N | X | Add review | 0.0 | |
Generic title: niacin systemic Drug class: nutritional supplements, mixed antihyperlipidemic brokers For users: dosage, interactions, side effects | |||||||
| Pravachol | Rx | X | N | Add review | 0.0 | ||
Generic title: pravastatin systemic Medication course: statins For users: dosage, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information | |||||||
| pravastatin | Rx | X | N | Add review | 0.0 | ||
Generic title: pravastatin systemic Brand title: Pravachol Medication course: statins For users: dosage, interactions, For specialists: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Lipofen | Rx | C | N | Add review | 0.0 | ||
Generic title: fenofibrate systemic Drug class: fibric acid derivatives For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| Niacin SR | Rx/OTC | C | N | X | Add review | 0.0 | |
Generic title: niacin systemic Drug class: nutritional supplements, mixed antihyperlipidemic brokers For users: dosage, interactions, side effects | |||||||
| Lofibra | Rx | C | N | Add review | 0.0 | ||
Generic title: fenofibrate systemic Drug class: fibric acid derivatives For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| Tri-glide | Rx | C | N | Add review | 0.0 | ||
Generic title: fenofibrate systemic Drug class: fibric acid derivatives For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| Antara | Rx | C | N | Add review | 0.0 | ||
Generic title: fenofibrate systemic Drug class: fibric acid derivatives For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| B-3-50 | Rx/OTC | C | N | X | Add review | 0.0 | |
Generic title: niacin systemic Drug class: nutritional supplements, mixed antihyperlipidemic brokers For users: dosage, interactions, side effects | |||||||
| Nicotinex | Rx/OTC | C | N | X | Add review | 0.0 | |
Generic title: niacin systemic Drug class: nutritional supplements, mixed antihyperlipidemic brokers For users: dosage, interactions, side effects | |||||||
| Fenoglide | Rx | C | N | Add review | 0.0 | ||
Generic title: fenofibrate systemic Drug class: fibric acid derivatives For users: dosage, interactions, side effects For specialists: Prescribing Information | |||||||
| B3-500-Gr | Rx/OTC | C | N | X | Add review | 0.0 | |
Generic title: niacin systemic Drug class: nutritional supplements, mixed antihyperlipidemic brokers For users: dosage, interactions, negative effects | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | On The Counter |
| Rx/OTC | Prescription or Over The Counter |
| Off Label | This drug might not be accepted by the FDA for the treatment of this illness. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to present a risk to the fetus in the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in elderly women. |
| C | Animal research studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant use in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may justify use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with use in elderly women clearly outweigh potential gains. |
| N | FDA have not classified the medication. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | Is not at the mercy of the Controlled Substances Act. |
| Inch | includes a high possibility of misuse. Has no currently accepted medical use in treatment in the United States. There`s a lack of accepted safety for use under medical supervision. |
| 2 | includes a high possibility of misuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may result in acute emotional or physical dependence. |
| 3 | Has a possibility for abuse less than individuals in schedules 1 and 2 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | includes a very low potential for abuse relative to individuals in program 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence. |
| 5 | includes a very low potential for abuse relative to individuals in program 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 4. |
| Infection | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Plans
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always seek advice from with your physician to make sure the information displayed on these pages applies to your personal circumstances.
Top USA Pharma Companies
Popular Categories
Easily find an affordable health insurance plan
